-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 29, Haisco issued an announcement stating that the company had recently received the "Notice of Acceptance" for HSK31868 tablets issued by the National Medical Products Administration
HSK31858 tablets are an oral, potent and highly selective Dipeptidyl Peptidase 1 (DPP1) small molecule inhibitor independently developed by the company.
The prevalence of bronchiectasis increases with age.
After inquiries, the world’s fastest-growing co-target compound INS1007 is currently undergoing phase III clinical trials, and its phase II trial results show that it has a definite effect on bronchiectasis.